Araris Biotech AG Announces Strategic Investment with
Samsung Ventures makes investment in ArarisProceeds will be used to support further development and advancement of Araris’ antibody-drug conjugate (ADC)...
Source: globenewswire.com
Page 3 - Sci Communications News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Sci Communications. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Sci Communications Today - Breaking & Trending Today
Araris Biotech AG to Present Preclinical Data at American
ZURICH, Switzerland, March 14, 2023 (GLOBE NEWSWIRE) -- Araris Biotech AG, a company pioneering a proprietary antibody-drug conjugate (ADC)-linker...
Source: globenewswire.com
Selecta Biosciences to Participate at the SVB Securities
WATERTOWN, Mass., Feb. 07, 2023 (GLOBE NEWSWIRE) -- Selecta Biosciences, Inc. (NASDAQ: SELB), a biotechnology company leveraging its clinically validated...
Source: globenewswire.com
Providence Therapeutics Appoints Robert Georgantas, Ph.D. as President and Chief Technology Officer
Providence Therapeutics Appoints Robert Georgantas, Ph.D. as President and Chief Technology Officer - read this article along with other careers information, tips and advice on BioSpace
Source: biospace.com
9 Meters Biopharma Announces Phase 3 Study of Vurolenatide in Short Bowel Syndrome
Study design incorporates two primary endpoints to evaluate the efficacy of vurolenatide in short bowel syndrome with or without parenteral support dependenceStudy design allows for the assessment of the
Source: finanznachrichten.de